Pediatric Tuberculosis: The Essentials October 8, 2014

Size: px
Start display at page:

Download "Pediatric Tuberculosis: The Essentials October 8, 2014"

Transcription

1 Pediatric Tuberculosis: The Essentials Ann M Loeffler, MD Randall Children s Hospital at Legacy Emanuel Portland, Oregon Curry International TB Center Disclosures Nothing to disclose Learning Objectives Explain the key differences in clinical presentation, infectiousness, and diagnosis (including interpretation of x rays) in children versus adults to best evaluate and ensure timely diagnosis in this population State the differences in treatment of TB and LTBI in children as compared to adults to achieve optimum pediatric patient outcomes List techniques to make children's medication dosing more effective and implement these techniques in their pediatric patients Monitor pediatric TB patients, including interpreting lab results, assessing the weight of infant patients, and determining clinical progress in pre verbal patients for optimum pediatric patient outcomes Address some of the challenges of working with parents of children with TB disease or LTBI and identify strategies to overcome them 1

2 Why do kids get their own talk? They re so darn cute Why else? They are disproportionately affected by TB Higher case rates considering their overall risk of exposure Infants and toddlers at particular risk 40% of exposed babies will develop disease 25% of exposed toddlers will develop disease High rates of disseminated disease Among infants < 1 yr of age 8.2% had meningeal disease 4.7% had miliary disease AND A new diagnosis of LTBI or TB disease in a young child reflects recent transmission Recent transmission is a public health opportunity 2

3 Reasons for TB Diagnosis Symptomatic Children with symptoms concerning for TB undergo evaluation 52% of US kids with TB diagnosed because of symptoms or abnormal chest radiograph 80% of all US cases Contact investigation Children screened because they have known or suspected TB exposure 43% of US kids with TB diagnosed during CI 4.6% of all US cases (n = 444) Universal or targeted screening Asymptomatic children undergo TST / IGRA Just a few percent of adults and children diagnosed with TB this way General Screening Few children require routine TST / IGRA Targeted testing Test children likely to be infected Test adults who are likely to develop disease if infected Treat all children deemed to have LTBI Treat adults at risk of progression to TB disease Don t test folks who you won t treat if positive 3

4 US Pediatric TB Cases by Case Verification Criterion*, N=19,840 Provider Diagnosis 23% Laboratory Confirmed 26% Clinical Case 51% *Based on the public health surveillance definition for TB [MMWR 1997:46(No. RR-10):40-41] US Pediatric TB Cases by Case Verification Criterion by Age Group, Age < 1 23% n=1,992 N=19,840 Age % n=9,692 20% 51% 26% 54% Age 5 9 n=4,474 Age n=3,682 24% 16% 16% 37% 60% 46% Laboratory Confirmed Clinical Case Provider Diagnosis 4

5 TB Diagnosis Adults Suspicious symptoms or radiographic changes Collect sputum (high quality x 3) If smear or NAAT positive OR Suspicious exposure history / demographics OR Classic radiographic findings / symptoms OR High risk contacts Start TB treatment Otherwise, consider awaiting more data / culture results TB Diagnosis Children Screened during contact investigation TST / IGRA Immediate History and Physical exam Immediate chest radiograph (2 views please) if: Less than five years of age OR Immunocompromised OR Signs or symptoms of TB disease OR Positive TST / IGRA Treat for TB disease if abnormal chest radiograph typical for TB disease, even if asymptomatic, even if TST / IGRA negative (ideally after culture collection) Not TB Disease Calcified granulomata OR pulmonary vessels on end Isolated calcified lymph nodes Isolated pleural thickening Most peribronchial thickening Most hilar fullness not confirmed on lateral 5

6 Isolated calcifications without parenchymal changes or enlargement of lymph nodes is LTBI. It is not TB disease Hilar nodes Lymph nodes in the hilum or mediastinum are seen as fullness in the infrahilar window 6

7 Paratracheal node Treat for LTBI Other diagnosis confirmed, Course inconsistent with TB Clinically and radiographically Normal Consistent with TB Positive TB skin test Abnormal More consistent with other diagnosis Collect cultures and Patient t very stable? start 4 drug TB therapy NO YES TB still possible? Reassess weekly *** Cultures only help if they are positive* Consider culture collection (NO INH!!!) Treat other diagnosis Contagion Adults with pulmonary or laryngeal TB are contagious until proven otherewise Increased contagion with cavitary TB, smear positivity, lots of cough Other factors associated with transmission Young children are not contagious with TB Rare newborn have transmitted to others Older kids with extensive parenchymal disease, cavitary disease, lots of cough might transmit 7

8 TB Treatment Treatment of pediatric TB disease is not very different than adult TB treatment Any drug used in adults can be used in children Weight based dosing is key in children Drug metabolism is typically faster in children and so their relative doses might seem high BUT do not exceed adult maximum unless you are monitoring drug levels (RARE) Pediatric TB Treatment Four drug initial therapy for most children Some experts would administer 3 drugs (isoniazid, rifampin, and pyrazinamide) as the initial regimen if a source case has been identified with known pansusceptible M tuberculosis, if the presumed source case has no risk factors for drug resistant M tuberculosis, or if the source case is unknown but the child resides in an area with low rates of isoniazid resistance AAP RedBook 8

9 Pediatric TB Drug Dosing Drugs Dosage forms Daily dose mg/kg Isoniazid Rifampin Tablets 100 & 300 mg; Syrup 10mg/ml Capsules 150 & 300 mg; Syrup; IV Twice weekly dose Maximum dose mg/kg mg/kg Daily 300mg Twice weekly DOT 900 mg mg/kg mg/kg 600 mg Pyrazinamide Tablets 500 mg mg/kg 50 mg/kg 2000 mg Ethambutol Tablets 100, 20 mg/kg 50 mg/kg 2500 mg 400 mg 2012 AAP RedBook Treatment Regimens Drug susceptible disease: the same as adults: 2 months of 3 4 drugs by DOT 4 months of 2 drugs (INH & RIF) by DOT INH monoresistant Rifampin, pyrazinamide and ethambutol for 6 + months Susceptible M. bovis: 2 months of INH, RIF, EMB, followed by 7 10 mo of isoniazid and rifampin Labs / pyridoxine All individuals with TB disease should be HIV tested (HIV is now rare in US children) Other labs are not routine in children unless they have underlying liver problems or take other hepatotoxic drugs Vitamin i B 6 supplementation ti is probably bbl not necessary in children whose diet includes milk and meat (except HIV infected or exclusively breastfeeding or adolescence) Many health departments prefer to use vitamin B6: Dose 25 mg tab: ¼ tab for babies; ½ tab for toddlers; 1 tab for older 9

10 LTBI Latent TB Infection LTBI M tuberculosis complex infection positive TST or IGRA result, no physical findings of disease, chest radiograph findings that are normal or reveal evidence of healed infection (eg, calcification in the lung, hilar lymph nodes, or both) 2012 AAP RedBook Pediatric LTBI Treatment Isoniazid for 9 months (270 doses) Rifampin for 6 months (likely will change to 4 months) Isoniazid and rifapentine weekly for 12 doses by DOT Rifampin / pyrazinamide for 2 months LTBI Treatment Never start LTBI treatment until TB disease is ruled out This is not always comfortable Collect cultures, evaluate contacts t and start t multidrug treatment if you can t wait Two months of 4 drugs is treatment for LTBI 10

11 LTBI Adherence Ensure adherence Treat only those who truly have LTBI Be very compelling with the family A little well placed guilt can be a good thing Set up convenient monitoring and medication delivery systems Use quick and easy clinic forms: Resources Consider intermittent treatment by DOT Treatment: Ensure Adherence Sticker and calendar system Incentives Close monitoring at least monthly in person for several months to reinforce adherence and screen for side effects. Consider phone monitoring after several months for LTBI Monitoring Monitor weight at each visit Usually the weight increases impressively and doses may need to be adjusted Failure to gain weight is concerning for: Drug toxicity / side effects Failure to appropriately treat TB disease Monitor activity / energy / sleep Children sometimes become annoyingly more active on appropriate treatment 11

12 Toxicity is rare in kids Never give more than one month of meds at a time No routine LFT measurements except underlying liver disease; other hepatotoxic meds, HIV, adolescent girls, alcohol use, symptoms Transient transaminase elevation is COMMON! Address ALT more than 3 x ULN if symptomatic Address ALT more than 5 x ULN if asymptomatic Most liver toxicity will occur in the first few months but families must be able to recite the symptoms: Loss of appetite, malaise, abdominal pain, nausea and vomiting, jaundice (a later finding don t wait) Families should stop treatment and seek care if three days of these symptoms and not improving Toxicity Treatment Sometimes the report of side effect actually reflects the parents discomfort with the diagnosis or value in treatment Ideally, the family will share their opinions so that you can address their concerns Most reported side effects are trivial (to us, not to parents) and can usually be worked around with some creativity and reassurance Try benadryl for mild, non urticarial rash Try bedtime dosing with food for stomach upset Avoid liquid suspension Consider brief drug holiday Isoniazid Suspension Avoid liquid suspension except in young babies The commercially available product is suspended in sorbitol. Sorbitol is a huge molecule which pulls fluid into the intestinal lumen Half of older kids have stomach upset, cramping & diarrhea with liquid INH Babies tend to do fine (the dose is smaller) dose needs to be adjusted frequently for weight gain 12

13 Other Suspensions Avoid liquid suspension except in young babies Pharmacies can compound the INH (and other TB drugs) into extemporaneous solutions, usually with simple syrup These medications have unknown stability and poor homogeneity INH breaks down into hydrazine (rocket fuel component) in sugary liquid Suspend at the time of delivery if this is the preferred method Medication Delivery Every single child is different Every single child / parent dynamic is different I like to empower the family and public health team to find the best delivery system for that child and at that time This may mean that the parents take the lead or take the back seat Advanced Medication Delivery I prefer to avoid the liquid products I like to teach older kids to swallow the pills or fractions of pills I have failed a couple of teens lately and will use anxiolytics sooner in the future (or call an experienced adult clinician) 13

14 Sandwich Technique My favorite system is the sandwich technique (also works for clindamycin): Layer soft, tasty vehicle with fragments of pills, powder from pills or capsules Fragments of pills have less bad taste than pulverized powder Some kids taste the product less if they take a popsicle first or eat some of the untainted food first Vehicles (not trucks, boats, trains..) Yummy foods have to be able to swallow without mushing around in the mouth too much Some folks swear by Hershey s chocolate ice cream topping Nutella Baby foods Jelly, maple syrup Whipped cream / chocolate whipped cream Savory foods (some kids don t like sweet things) Time for questions 14

15 Thank you for your care of the children 15

PEDIATRIC TUBERCULOSIS

PEDIATRIC TUBERCULOSIS PEDIATRIC TUBERCULOSIS Ann M. Loeffler, M.D. Faculty Consultant Curry International Tuberculosis Center Objectives At the end of this session, participants will be able to describe: how pediatric patients

More information

PEDIATRIC TUBERCULOSIS. Objectives. Children are not just small adults. Pediatric Tuberculosis 1

PEDIATRIC TUBERCULOSIS. Objectives. Children are not just small adults. Pediatric Tuberculosis 1 PEDIATRIC TUBERCULOSIS Ann M. Loeffler, M.D. Faculty Consultant Curry International Tuberculosis Center Objectives At the end of this session, participants will be able to describe: how pediatric patients

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

LTBI Videos-Treatment

LTBI Videos-Treatment LTBI Videos-Treatment This program is presented by the Global Tuberculosis Institute and is based on recommendations from the Centers for Disease Control and Prevention. This is the third in a series of

More information

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following disclosures

More information

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI:

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI: Pre-Treatment Evaluation Before initiating treatment for LTBI: Treatment of Latent TB Infection (LTBI) Amee Patrawalla, MD Associate Professor, New Jersey Medical School Attending Physician, NJMS Global

More information

Contact Investigation and Prevention in the USA

Contact Investigation and Prevention in the USA Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis

More information

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015 Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015 Tuberculosis Infection Diagnosis and Treatment April 7, 2015 El Paso, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has

More information

Pediatric Tuberculosis. Ann M. Loeffler, MD Pediatric TB Consultant Curry International Tuberculosis Center

Pediatric Tuberculosis. Ann M. Loeffler, MD Pediatric TB Consultant Curry International Tuberculosis Center Pediatric Tuberculosis Ann M. Loeffler, MD Pediatric TB Consultant Curry International Tuberculosis Center Introduction Basic situations in which children are evaluated Diagnosis and treatment of latent

More information

Chapter 5 Treatment for Latent Tuberculosis Infection

Chapter 5 Treatment for Latent Tuberculosis Infection Chapter 5 Treatment for Latent Tuberculosis Infection Table of Contents Chapter Objectives.... 109 Introduction.... 111 Candidates for the Treatment of LTBI... 112 LTBI Treatment Regimens.... 118 LTBI

More information

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH V. TB and HIV/AIDS A. Standards of Treatment and Management The majority of TB treatment principles apply to persons with HIV/AIDS who require treatment for TB disease. The following points are either

More information

Pediatric TB Basics and Evaluation and Management of Exposed Neonates

Pediatric TB Basics and Evaluation and Management of Exposed Neonates Pediatric TB Basics and Evaluation and Management of Exposed Neonates Ann M. Loeffler, MD Randall Children s Hospital, Portland OR & Curry International TB Center, Oakland CA September, 2017 No Disclosures

More information

Tuberculosis (TB) Fundamentals for School Nurses

Tuberculosis (TB) Fundamentals for School Nurses Tuberculosis (TB) Fundamentals for School Nurses June 9, 2015 Kristin Gall, RN, MSN/Pat Infield, RN-TB Program Manager Marsha Carlson, RN, BSN Two Rivers Public Health Department Nebraska Department of

More information

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH Assistant Professor University of Texas Health Science Center Staff Physician, Texas Center for Infectious Diseases TB Nurse Case

More information

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Nurse Case Management San Antonio, Texas July 18 20, 2012 Pediatric TB Kim Smith, MD, MPH July 19, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.

More information

Fundamentals of Tuberculosis (TB)

Fundamentals of Tuberculosis (TB) TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported

More information

Diagnosis and Treatment of Tuberculosis, 2011

Diagnosis and Treatment of Tuberculosis, 2011 Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is

More information

Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012

Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 LTBI and TB Disease Treatment Cara Christ, MD, MS May 8, 2012 Cara Christ, MD, MS has the following disclosures to make: No conflict

More information

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 TB Nurse Case Management San Antonio, Texas March 7 9, 2012 Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

CDC Immigration Requirements: Tuberculosis Screening for Children

CDC Immigration Requirements: Tuberculosis Screening for Children CDC Immigration Requirements: Tuberculosis Screening for Children Ann M. Loeffler, M.D. Curry International TB Center San Francisco, CA March, 2013 Atlanta, Georgia CDC Immigration Requirements: Tuberculosis

More information

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009 TB Intensive Houston, Texas November 10-12, 12 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 1 OUTLINE Stages

More information

has the following disclosures to make:

has the following disclosures to make: CLINICAL DIAGNOSIS AND MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH September 22, 2015 TB Nurse Case Management September 22 24, 2015 San Antonio. TX EXCELLENCE EXPERTISE INNOVATION Annie Kizilbash

More information

Tuberculosis Intensive

Tuberculosis Intensive Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Childhood Tuberculosis Kim Smith, MD, MPH April 6, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015

Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015 Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015 Initiation Phase Part 1 Ginny Dowell, RN, BSN February 4, 2015 Ginny Dowell RN, BSN has the following disclosures to make:

More information

Management of Pediatric Tuberculosis in New Jersey

Management of Pediatric Tuberculosis in New Jersey Management of Pediatric Tuberculosis in New Jersey Helen Aguila, MD NJMS Global TB Institute December 15, 2011 This presentation is in part adapted from Pediatric Tuberculosis by Ann Loeffler, MD : Francis

More information

Contact Investigation

Contact Investigation Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period

More information

TB Contact Investigation

TB Contact Investigation Ann Raftery, RN, PHN, MS Curry International TB Center Overview Contact investigation as a core TB control and elimination activity Components of TB Contact Investigation TB Control Priority Strategies.

More information

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017 Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has

More information

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015 Diagnosis & Medical Case Management of TB Disease Lisa Armitige, MD, PhD October 22, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE

More information

TB in Corrections Phoenix, Arizona

TB in Corrections Phoenix, Arizona TB in Corrections Phoenix, Arizona March 24, 2011 Treatment of Latent TB Infection Renuka Khurana MD, MPH March 24, 2011 Renuka Khurana, MD, MPH has the following disclosures to make: No conflict of interests

More information

Northwestern Polytechnic University

Northwestern Polytechnic University Clinical Tuberculosis Assessment by Health Care Provider Clinicians should review and verify the information in the Tuberculosis (TB) Screening Questionnaire (attached). Persons answering YES to any questions

More information

Tuberculosis: A Provider s Guide to

Tuberculosis: A Provider s Guide to Tuberculosis: A Provider s Guide to Diagnosis and Treatment of Active Tuberculosis (TB) Disease and Screening and Treatment of Latent Tuberculosis Infection (LTBI) Alameda County Health Care Services Agency

More information

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015 Diagnosis and Medical Management of TB Disease Quratulian Annie Kizilbash, MD, MPH March 17, 2015 TB Nurse Case Management March 17 19, 2015 San Antonio, Texas EXCELLENCE EXPERTISE INNOVATION Quratulian

More information

Treatment of Tuberculosis, 2017

Treatment of Tuberculosis, 2017 Treatment of Tuberculosis, 2017 Charles L. Daley, MD National Jewish Health University of Colorado Health Sciences Center Treatment of Tuberculosis Disclosures Advisory Board Horizon, Johnson and Johnson,

More information

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012 TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release

More information

Treatment of Tuberculosis

Treatment of Tuberculosis TB Clinical i l Intensive Seattle Treatment of Tuberculosis June 16, 2016 Masa Narita, MD Public Health Seattle & King County; Firland Northwest TB Center, University of Washington Outline Unique features

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 7 References Related ACA Standards 4 th Edition Standards for Adult Correctional Institutions 4-4350, 4-4355 These guidelines are based on the recommendations of the American Thoracic Society

More information

Disclosures. Outline. No disclosures or conflicts of interest to report. Special LTBI situations. H t it d id ff t

Disclosures. Outline. No disclosures or conflicts of interest to report. Special LTBI situations. H t it d id ff t Selected Topics in LTBI June 2, 2015 Bijan Ghassemieh, MD Senior Fellow UW Division of Pulmonary/Critical Care Disclosures No disclosures or conflicts of interest to report Outline Special LTBI situations

More information

Treatment and Monitoring

Treatment and Monitoring Treatment and Monitoring Disclosures We have no actual or potential conflicts of interest in relation to this presentations. We have no financial relationships to disclose. Learning Objectives After this

More information

TB Update: March 2012

TB Update: March 2012 TB Update: March 2012 David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Public Health 1 TB Update: March 2012 IGRAs vs TST LTBI A New Regimen NAATs What is Their

More information

Managing the Patients Response to TB Treatment

Managing the Patients Response to TB Treatment Managing the Patients Response to TB Treatment Barbarah Martinez, RN, BSN September 13, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Barbarah Martinez, RN, BSN has

More information

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population

More information

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease Barbara J Seaworth MD Medical Director Heartland National TB Center Professor of Medicine University of Texas Health Center Tyler Barbara J Seaworth MD has

More information

Pediatric TB Intensive Houston, Texas

Pediatric TB Intensive Houston, Texas Pediatric TB Intensive Houston, Texas November 13, 2009 Treatment of Pediatric TB Jeffrey R. Starke, M.D. November 13, 2009 MANAGEMENT OF CHILDHOOD TUBERCULOSIS Jeffrey R. Starke, M.D. Professor of Pediatrics

More information

Treatment of Active Tuberculosis

Treatment of Active Tuberculosis Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest

More information

TUBERCULOSIS CONTACT INVESTIGATION

TUBERCULOSIS CONTACT INVESTIGATION TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used

More information

Treatment of Latent TB Infection (LTBI)

Treatment of Latent TB Infection (LTBI) Treatment of Latent TB Infection (LTBI) Mahesh C. Patel, MD June 14, 2017 2014 MFMER slide-1 Mahesh C. Patel, MD Associate Professor Treatment of LTBI Department of Internal Medicine, Division of Infectious

More information

TUBERCULOSIS. Pathogenesis and Transmission

TUBERCULOSIS. Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are

More information

Pediatric TB Intensive Houston, Texas October 14, 2013

Pediatric TB Intensive Houston, Texas October 14, 2013 Pediatric TB Intensive Houston, Texas October 14, 2013 Diagnosis and Management of Tuberculosis in Adolescents Andrea T. Cruz, MD, MPH Sections of Infectious Diseases & Emergency Medicine October 14, 2013

More information

LTBI in Special Populations John Nava, MD October 5, 2010

LTBI in Special Populations John Nava, MD October 5, 2010 Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 LTBI in Special Populations John Nava, MD October 5, 2010 2 Treatment of Latent TB Infection in Special Populations John

More information

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats Tuberculosis Facts Below are frequently asked questions about TB, and their answers. If you have additional questions you may contact the City of Ennis Department of Health Services at 972-875-1234 or

More information

TB Intensive San Antonio, Texas August 7-10, 2012

TB Intensive San Antonio, Texas August 7-10, 2012 TB Intensive San Antonio, Texas August 7-10, 2012 An Introduction to Childhood Tuberculosis Kim Smith, MD, MPH August 10, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 1 Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 Daniel P. Dohony, MPH Division of Tuberculosis Elimination Centers for Disease Control and Prevention and Philadelphia TB Control

More information

Pediatric TB Radiology: It s Not Black and White Part 2

Pediatric TB Radiology: It s Not Black and White Part 2 Experiencing technical difficulties? Please call Adobe Connect for technical assistance at 1-800-422-3623 Pediatric TB Radiology: It s Not Black and White Part 2 June 18, 2018 A National Webinar June 18,

More information

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection? Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:

More information

Sharing the Care: Working Together on LTBI Treatment and Management Webinar. September 24, Curry International Tuberculosis Center

Sharing the Care: Working Together on LTBI Treatment and Management Webinar. September 24, Curry International Tuberculosis Center TB Infection Diagnostics and Treatment Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention 1 Curry International

More information

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TUBERCULOSIS. Presented By: Public Health Madison & Dane County TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any

More information

Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013

Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013 Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013 1 TB in Toronto - risk groups Diagnosis of active TB LTBI diagnosis and management Infection control 2 TB in Toronto Case

More information

INDEX CASE INFORMATION

INDEX CASE INFORMATION Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.

More information

Pediatric Tuberculosis

Pediatric Tuberculosis Pediatric Tuberculosis Rafael E. Hernandez, MD PhD Attending Physician, Instructor Pediatric Infectious Diseases Seattle Children s Hospital & University of Washington Disclosures No financial conflicts

More information

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea

More information

Santa Clara County Tuberculosis Screening Requirement for School Entrance Effective June 1, 2014

Santa Clara County Tuberculosis Screening Requirement for School Entrance Effective June 1, 2014 Guidelines to Revisions to the School Mandate and Requirements 1) What are the tuberculosis (TB) screening requirements for school entrance in Santa Clara County? Students must undergo a TB risk assessment

More information

Let s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Let s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Lancelot M. Pinto, MD, MSc Author Madhukar Pai, MD, PhD co-author and Series Editor Abstract Nearly 50% of patients with

More information

At the end of this session, participants will be able to:

At the end of this session, participants will be able to: Advanced Concepts in Pediatric Tuberculosis: Infection Control, Source Case and Contact Investigation Ana M. Alvarez, M.D. Associate Professor Division of Pediatric Infectious Diseases and Immunology University

More information

TB in the Patient with HIV

TB in the Patient with HIV TB in the Patient with HIV Lisa Y. Armitige, MD, PhD May 11, 2017 TB Intensive May 9 12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD, has the following disclosures to

More information

Drug Interactions Lisa Armitige, MD, PhD November 17, 2010

Drug Interactions Lisa Armitige, MD, PhD November 17, 2010 Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010 Drug Interactions Lisa Armitige, MD, PhD November 17, 2010 Drug Interactions Lisa Y. Armitige, M.D., Ph.D. Medical Consultant

More information

Tuberculosis Tools: A Clinical Update

Tuberculosis Tools: A Clinical Update Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary

More information

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis? Tuberculosis Understanding, Investigating, Eliminating Jeff Maupin, RN Tuberculosis Control Nurse Sedgwick County Division of Health Objectives At the conclusion of this presentation, you will be able

More information

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition Pulmonary Tuberculosis Debra Mercer BSN, RN, RRT Definition Tuberculosis is a contagious bacterial infection of the lungs caused by Mycobacterium Tuberculosis (TB) Etiological Agent: Mycobacterium Tuberculosis

More information

Latent TB Infection Treatment

Latent TB Infection Treatment Latent TB Infection Treatment Douglas B. Hornick, MD Pulmonologist w/ Infectious Attitude Division of Pulmonary/Critical Care/Occ Med UI Carver College of Medicine 2014 MFMER slide-1 Disclosures: None

More information

Latent tuberculosis infection

Latent tuberculosis infection EXECUTIVE SUMMARY Latent tuberculosis infection Updated and consolidated guidelines for programmatic management Executive summary Latent tuberculosis infection (LTBI) is defined as a state of persistent

More information

Disclosures. Current Issues and Controversies in Child and Adolescent Tuberculosis 02/24/2016. NSTC 2016 Annual Meeting

Disclosures. Current Issues and Controversies in Child and Adolescent Tuberculosis 02/24/2016. NSTC 2016 Annual Meeting Current Issues and Controversies in Child and Adolescent Tuberculosis Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea Cruz, M.D.] Disclosures Dr.

More information

Pediatric Tuberculosis

Pediatric Tuberculosis Pediatric Tuberculosis Kim Connelly Smith, MD, MPH April 7, 2016 TB Intensive April 5 8, 2016 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Kim Connelly Smith, MD, MPH has the following disclosures to

More information

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014 Sharing the Care: Working Together to Meet the Challenge of TB Presented by: Barbara Cole, RN, PHN, MSN Director, Disease Control County of Riverside Department of Public Health Curry International TB

More information

Communicable Disease Control Manual Chapter 4: Tuberculosis. Assessment and Follow-Up of TB Contacts

Communicable Disease Control Manual Chapter 4: Tuberculosis. Assessment and Follow-Up of TB Contacts Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Assessment and Follow-Up of TB July, 2018 Page 1 TABLE OF CONTENTS 8.0 ASSESSMENT AND

More information

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014 What you need to know about diagnosing and treating TB: a preventable, fatal disease Bob Belknap M.D. Denver Public Health November 2014 The Critical First Step Consider TB in the Differential 1. Risks

More information

Isoniazid Preventive Therapy (IPT)

Isoniazid Preventive Therapy (IPT) Isoniazid Preventive Therapy (IPT) Josefina Cadorna-Carlos, M.D. Professor of Pediatrics U E R M M M C Objectives 1. Define IPT. 2. Discuss the indications for IPT. 3. Present RCT s for IPT (6H vs 9H).

More information

TB PREVENTION: TREATMENT OF LATENT TB INFECTION AND BCG VACCINATION

TB PREVENTION: TREATMENT OF LATENT TB INFECTION AND BCG VACCINATION TB PREVENTION: TREATMENT OF LATENT TB INFECTION AND BCG VACCINATION Michelle Haas, M.D. Denver Metro Tuberculosis Program Denver Public Health DISCLOSURES No relevant financial relationships OBJECTIVES

More information

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction SECOND EDITION 2009 Madhukar Pai McGill University Introduction 1 Purpose of ISTC ISTC Version 2: Key Points 21 Standards Differ from existing guidelines: standards present what should be done, whereas,

More information

Pediatric Tuberculosis

Pediatric Tuberculosis Pediatric Tuberculosis Rafael E. Hernandez, MD PhD Attending Physician, Instructor Pediatric Infectious Diseases Seattle Children s Hospital & University of Washington Disclosures No financial conflicts

More information

Pediatric Tuberculosis

Pediatric Tuberculosis Pediatric Tuberculosis Rafael Hernandez, MD PhD Attending Physician, Instructor Pediatric Infectious Diseases Disclosures No financial conflicts Off-label use: Drugs used in typical HZRE regimens are approved

More information

TB Intensive Houston, Texas October 15-17, 2013

TB Intensive Houston, Texas October 15-17, 2013 TB Intensive Houston, Texas October 15-17, 2013 Tuberculosis in Children Kim Connelly Smith, MD, MPH October 16, 2013 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

Latent TB, TB and the Role of the Health Department

Latent TB, TB and the Role of the Health Department Latent TB, TB and the Role of the Health Department Elaine Darnall, RN, BSN, CIC TB Nurse Consultant Illinois Dept of Public Health March 21, 2018 Elaine Darnall has disclosed that there is no actual or

More information

TB Nurse Case Management Waukesha, Wisconsin March 31 April 2, Pediatric TB Michelle Hulse, MD April 1, 2009

TB Nurse Case Management Waukesha, Wisconsin March 31 April 2, Pediatric TB Michelle Hulse, MD April 1, 2009 TB Nurse Case Management Waukesha, Wisconsin March 31 April 2, 2009 Pediatric TB Michelle Hulse, MD April 1, 2009 Pediatric Tuberculosis HNTC Nurse Case Management Course April 1, 2009 Waukesha, Wisconsin

More information

TB Classification (ATS/CDC)

TB Classification (ATS/CDC) bits and pieces Lisa Chen, MD UCSF Pulmonary/Critical Care Curry International Tuberculosis Center 10/2017 TB Classification (ATS/CDC) TB0 No tuberculosis exposure, not infected TB1 Tuberculosis exposure,

More information

TB the basics. (Dr) Margaret (DHA) and John (INZ)

TB the basics. (Dr) Margaret (DHA) and John (INZ) TB the basics (Dr) Margaret (DHA) and John (INZ) Question 1 The scientist who discovered M. tuberculosis was: A: Louis Pasteur B: Robert Koch C: Jean-Antoine Villemin D: Calmette and Guerin Question 2

More information

Management of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015

Management of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015 Management of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015 Tuberculosis Infection Diagnosis and Treatment April 7, 2015 El Paso, TX EXCELLENCE EXPERTISE INNOVATION Catalina Navarro,

More information

Tuberculosis - clinical forms. Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases

Tuberculosis - clinical forms. Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases Tuberculosis - clinical forms Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases 1 TB DISEASE Primary Post-primary (Secondary) Common primary forms Primary complex Tuberculosis of the intrathoracic

More information

Tuberculosis Populations at Risk

Tuberculosis Populations at Risk Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading

More information

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 What is Latent TB Infection (LTBI)? Traci Hadley, RN October 5, 2010 LTBI or TB Disease? Presented by : Traci Hadley, RN

More information

Tuberculosis Education for the Medical Professional

Tuberculosis Education for the Medical Professional Tuberculosis Education for the Medical Professional North Dakota Diagnosis and Medical Management of Latent TB Infection Dawn Farrell, RN, BSN, PHN Maria Robles, BSN July 10, 2007 Tuberculosis Education

More information

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 Lisa Armitige, MD, PhD has the following disclosures to make:

More information

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No

More information

Pediatric TB Theresa Barton, MD

Pediatric TB Theresa Barton, MD TB Nurse Case Management San Antonio, Texas December 8-10, 2009 Pediatric TB Theresa Barton, MD December 9, 2009 Pediatric Tuberculosis Tess Barton, MD Assistant Professor of Pediatrics UT Southwestern

More information

Ian Kitai TB Specialist. Division of Infectious Diseases Sickkids

Ian Kitai TB Specialist. Division of Infectious Diseases Sickkids Ian Kitai TB Specialist Division of Infectious Diseases Sickkids Review Clinical presentation of TB disease childhood How to assess risk for TB infection How to assess risk for disease if infected TST

More information

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers Who Should Be Screened for Latent Tuberculosis Infection (LTBI)?... 2 What tests are used to screen for LTBI?... 2 How

More information